Emily’s Entourage speeds lifesaving research and drug development for individuals in the final 10% of the cystic fibrosis (CF) community that do not benefit from currently available mutation-targeted therapies.
SUBVENCIONES QUE FINANCIAMOS
EE ha concedido millones de dólares a equipos multidisciplinares de todo el mundo para avanzar en la investigación y el desarrollo de fármacos para la 10% final de las personas con FQ.
On October 11, 2025, join us for the 2025 Evening with Emily’s Entourage gala as we step into a new era—one defined by clarity, precision, and fast progress for the final 10% of the cystic fibrosis community. The future is coming into focus.
Emily’s Entourage CF Clinical Trial Connect (CTC) is the only global patient database exclusively for people with CF who are unable to benefit from CFTR modulators. By joining, you can help accelerate the development of new, lifesaving CF therapies.
There’s a certain magic to the weekend of the Philadelphia Marathon that’s hard to put into words—a mix of determination, excitement, and heart that fills... Lee mas
In just a few weeks—on November 23 and 24, 2024—our unstoppable #TeamEE runners will lace up their sneakers, hit the pavement, and take on the... Lee mas
By Chandra Ghose, PhD, Chief Scientific Officer at Emily’s Entourage Every fall, the North American Cystic Fibrosis Conference (NACFC) brings together our community with renewed... Lee mas
En una radiante noche de sábado, 5 de octubre de 2024, el Mann Center for Performing Arts de Filadelfia se convirtió en un faro de esperanza y unidad... Lee mas